Lung cancer is a major public health problem in Brazil; estimates from GLOBOCAN, produced by the International Agency for Research on Cancer, showed 44 213 new cases and 38 292 deaths in the country from lung cancer in 2022.1 The disease is associated with high morbidity, mortality, reduced quality of life, loss of productivity, and a considerably low survival rate.1 Lung cancer also imposes high costs on the Brazilian public health system (Sistema Único de Saúde [SUS]).2
55
Archynetys Health Desk
The Archynetys Health Desk covers public health, medical research, healthcare systems, wellness trends, and science-backed developments that affect readers globally. This desk applies added care to sourcing, evidence, nuance, and plain-language explanation, especially on high-impact health topics.
previous post
